The results of this animal trial are very promising, not only because our vaccine completely protected animals that otherwise would have died, but also because we found that one form of the vaccine stimulates several lines of immunity against H5N1.
Dr Andrea Gambotto
We have the technique to go from an email to a virus.
Eventually we will need to partner with a company for large-scale production of vaccine.
company
This is a very potent vaccine. It took roughly about 30 days to make the vaccine from when we received the sequence information from CDC in Atlanta.
information days
Bird flu may likely become the next pandemic, and this vaccine is worth investigating further.
worth bird
Using this technology we can have much broader protection, which is important because the virus is always changing.
technology protection changing important
Bird flu is something we should be prepared for, but even if a pandemic never happens, everything we learn now from this vaccine can be applied to vaccines for other emerging infectious diseases.
learn bird
That means there is a lot of chance of getting cross-reactivity.
chance
We generated the portion that we think was important for immunity. We never manipulated the actual H5N1 virus ourselves, so it is safe to generate this kind of vaccine.
kind safe important
results trial animals found animal form
This is a very potent vaccine. The results of this animal trial are very promising.
results trial animal
You must log in to post a comment.
There are no comments yet.